Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 8, 2008, Pages 801-805

  Cam, Sirri F ^a,e   Sekuri, Cevad ^b   Sagcan, Abdi ^b   Ercan, Ertugrul ^c   Tengiz, Istemihan ^c   Alioglu, Emin ^c   Berdeli, Afig ^d  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b KENT HOSPITAL   (Turkey)

^c Central Hospital Izmir   (Turkey)

^d EGE UNIVERSITY   (Turkey)

^e NONE   (Turkey)

Author keywords

Gene; Genetic; MCP 1; Polymorphism; Premature coronary artery disease

Indexed keywords

GENOMIC DNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CORONARY ARTERY DISEASE; DEMOGRAPHY; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY;

EID: 57349166669     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510802287257     Document Type: Article

References (34)

1. Ergun M, Islegen C. Coronary heart disease's risk factors and exercise. J Card Res 2006;2:23-33.
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
3. Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997;349:490-5.
4. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell 2001;104:503-16.
5. Yla-Herttuala S, Lifton B, Rosenfeld M, Sarkioja T, Yoshimura, Leonard EJ, et al. Expression of MCP-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991;88:5252-6.
6. Nelken N, Coughlin S, Gordon D, Wilcox J. MCP-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-7.
7. Yu X, Dluz S, Graves DT, Zhang L, Antoniades HN, Hollander W, et al. Elevated expression of MCP-1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 1992;89:6953-7.
8. Kowala M, Recce R, Beyer S, Gu C, Valentine M. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Atherosclerosis 2000;149:323-30.
9. Takeya M, Yoshimura T, Leonard EJ, Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. HumPathol 1993;24:534-9.
10. Deo R, Khera A, McGuire DK, Murphy SA, Neto JPM, Morrow DA, et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004;44:1812-18.
11. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, et al. Plasma levels of monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997;29:419-23.
12. Soejima H, Ogawa H, Yasue H, Kaikita K, Takazoe K, Nishiyama K, et al. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction. J Am Coll Cardiol 1999;34:983-8.
13. Aukrust P, Berge RK, Ueland T, Aaser E, Damas JK, Wikeby L, et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol 2001;37:485-91.
14. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001;21:327-34.
15. Oshima S, Ogawa H, Hokimoto S, Nakamura S, Noda K, Saito T, et al. Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation. Jpn Circ J 2001;65:261-4.
16. van Aken BE, den Heijer M, Bos GM, van Deventer SJ, Reitsma PH. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost 2000;83:536-9.
17. Jibiki T, Terai M, Shima M, Ogawa A, Hamada H, Kanazawa M, et al. Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum 2001;44:2211-12.
18. Rovin B, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999;259:344-8.
19. McGlinchey PG, Spence MS, Patterson CC, Allen AR, Murphy G, Belton C, et al. Lack of association between the -2518G/A polymorphism of the MCP-1 gene and ischaemic heart disease: a family-based investigation. Tissue Antigens 2004;64:199-203.
20. Hwang SY, Cho ML, Park B, Kim JY, Kim YH, Min DJ, et al. Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease. Eur J Immunogenet 2002;29:413-16.
21. Szalai C, Kozma GT, Nagy A, Bojszko A, Krikovszky D, Szabo, et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001;108:375-81.
22. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD): coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001;158:233-9.
23. Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001;58:335-8.
24. Ozyürek AR, Gürses D, Ulger Z, Levent E, Bakiler AR, Berdeli A. Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis. Clin Rheumatol 2007;26:546-50.
25. Simeoni E, Winkelmann BR, Hoffmann MM, Fleurya S, Ruize J, Kappenbergera L, et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 2004;25:1438-46.
26. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Circulation 1979;59:607-8.
27. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. National Institutes of Health. Obes Res 1998;6 Suppl 2:51S-209S.
28. Hirschhorn CJ, O'Donnell PM, Murphy EJ, Benjamin M, Massaro JF, Keaney Jr, et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 2005;112:1113-20.
29. Alonso-Villaverde C, Coll B, Parra S, Montero M, Calvo N, Tous M, et al. Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele. Circulation 2004;110:2204-9.
30. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002;347:1916-23.
31. Bjarnadottir K, Eiriksdottir G, Aspelund T, Gudnason V. Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population. Atherosclerosis 2006;188:341-6.
32. Cermakova Z, Petrkova J, Arakelyan A, Drabek J, Mrazek F, Luk J, et al. The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Intl J Immunogenet 2005;32:315-18.
33. Pola R, Flex A, Gaetani E, Proia AS, Papaleo P, Di Giorgio A, et al. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 2004;39:1249-52.
34. Tabara Y, Kohara K, Yamamoto Y, Igase M, Nakura J, Kondo I, et al. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 2003;26:677-83.